Madrigal Pharmaceuticals (MDGL) Market Cap 2007–2026

As of October 29, 2026, Madrigal Pharmaceuticals had a market cap of $9.97 billion, which increased by 0.16% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Madrigal Pharmaceuticals logo

Madrigal Pharmaceuticals, Inc. (MDGL)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$9.97B ▲ 0.16%
Start of 2026
$13.23B ▼ 24.64%
1 Year Ago
$9.709B ▲ 2.69%
All-Time High
$13.69B ▼ 27.17%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Madrigal Pharmaceuticals Market Cap History by Year and Month

Madrigal Pharmaceuticals Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$9.97B▼ 24.64%
$9.97B▼ 14.35%
$11.64B▼ 6.66%
$12.47B▲ 15.57%
$10.79B▼ 12.77%
$12.37B▲ 7.94%
$11.46B▼ 3.45%
$11.87B▼ 1.17%
$12.01B▲ 22.41%
$9.811B▼ 11.69%
$11.11B▼ 16.02%
2025$13.23B▲ 94.87%
2024$6.789B▲ 48.65%
2023$4.567B▼ 11.80%
2022$5.178B▲ 257.35%
All market cap values reflect closing prices for the period shown.

📊 Madrigal Pharmaceuticals Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:


Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.